Biomonitoring of fusarium spp. mycotoxins: Perspectives for an individual exposure assessment tool

Food Science and Technology International

Volumn 16, Issue 3, 2010, Pages 266-276

  Cano Sancho, G ^a   Marin, S ^a   Ramos, A J ^a   Sanchis, V ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

biomarkers; fumonisin; Fusarium; trichothecene; zearalenone

Indexed keywords

BIOCHEMICAL INDICATORS; BIOMONITORING; BIOMONITORS; DEOXYNIVALENOL; DIETARY INTAKES; EXPOSURE ASSESSMENT; FUMONISIN; FUSARIUM; FUSARIUM SPECIES; NIVALENOL; PROBABILISTIC METHODS; QUANTITATIVE EVALUATION; T-2 TOXIN; TEMPERATE REGIONS; TOXIN-PRODUCING FUNGI; TRICHOTHECENES; ZEARALENONE;

QUALITY CONTROL; TOXIC MATERIALS;

CHEMICAL CONTAMINATION;

FUNGI; FUSARIUM;

BIOLOGICAL MARKER; FUMONISIN;

ARTICLE; BLOOD; CHEMISTRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FOOD CONTAMINATION; FUSARIUM; HUMAN; METABOLISM; METHODOLOGY;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FOOD CONTAMINATION; FUMONISINS; FUSARIUM; HUMANS;

EID: 77956833284     PISSN: 10820132     EISSN: 15321738     Source Type: Journal    
DOI: 10.1177/1082013210368884     Document Type: Article

References (123)

1. Abnet C.C., Borkowf C.B., Qiao Y.-L., Albert P.S., Wang E., Merrill A.H., Mark S.D., Dong Z.-W., Taylor P.R. and Dawsey S.M. (2001). A cross-sectional study of human serum sphingolipids, diet and physiologic parameters. Journal of Nutrition 131: 2748-2752.
2. Beasley V.R., Swanson S.P. and Corley R.A. (1986). Pharmacokinetics of the trichothecene mycotoxin, T-2 toxin, in swine and cattle. Toxicon 24: 13-23.
3. Berthiller F., Schuhmacher R., Adam G. and Krska R. (2009). Formation, determination and significance of masked and other conjugated mycotoxins. Analytical and Bioanalytical Chemistry 395: 1243-1252.
4. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B. and Trenholm H.L. (1993). Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicology and Applied Pharmacology 121: 152-159.
5. Bottalico A. (1998). Fusarium diseases of cereals: species complex and related mycotoxin profiles, in Europe. Journal of Plant Pathology 80: 85-103.
6. Cai Q., Tang L. and Wang J. (2007). Validation of fumonisin biomarkers in F344 rats. Toxicology and Applied Pharmacology 225: 28-39.
7. Cast. (2003). Mycotoxins: risks in plant, animal and human system. Task Force Report Ames, IA No. 139, pp. 48-58.
8. Castegnaro M., Garren L., Galendo D., Gelderblom W.C.A., Chelule P., Dutton M.F. and Wild C.P. (1998). Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure. Journal of Chromatography Part B 720: 15-24.
9. Castegnaro M., Garren L., Gaucher I. and Wild C.P. (1996). Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues. Natural Toxins 4: 284-290.
10. Chelule P.K., Gqaleni N., Chuturgoon A.A. and Dutton M.F. (2000). The determination of fumonisin B1 in human faeces: a short term marker for assessment of exposure. Biomarkers 5: 1-8.
11. Chi M.S., Robison T.S. and Mirocha C.J. (1978). Excretion and tissue distribution of radioactivity from tritium-labeled T-2 toxin in chicks. Toxicology and Applied Pharmacology 45: 391-402.
12. Creppy E.E. (2002). Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicology Letters 127: 19-28.
13. Delongchamp R.R. and Young J.F. (2001). Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Food Additives and Contaminants 18: 255-261.
14. De Nijs M., Rombouts F. and Notermans S. (1996). Fusarium molds and their mycotoxins. Journal of Food Safety 16: 15-58.
15. Dohnal V., Jezkova A., Jun D. and Kuca K. (2008). Metabolic pathways of T-2 toxin. Current Drug Metabolism 9: 77-82.
16. Döll S., Danicke S. and Schnurrbusch U. (2003). The effect of increasing concentrations of Fusarium toxins in the diets of piglets on histological parameters of uterus. Mycotoxin Research 19: 73-76.
17. Eriksen G.S. and Pettersson H. (2004). Toxicological evaluation of trichothecenes in animal feed. Animal Feed Science and Technology 114: 205-239.
18. European Commission: Scientific Committee for Food (2003). Updated opinion of the Scientific Committee on Food on Fumonisin B1, B2 and B3. Available at http://ec.europa.eu/food/fs/sc/scf/out185-en.pdf (accessed May 20, 2010 ).
19. European Food Safety Authority (EFSA) (2004). Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to zearalenone as undesirable substance in animal feed. The EFSA Journal 73: 1-41.
20. Fodor J., Balogh K., Weber M., Mezes M., Kametler L., Posa R., Mamet R., Bauer J., Horn P., Kovacs F. and Kovacs M. (2008). Absorption, distribution and elimination of fumonisin B1 metabolites in weaned piglets. Food Additives and Contaminants Part A 25: 88-96.
21. Fodor J., Meyer K., Riedlberger M., Bauer J., Horn P., Kovacs F. and Kovacs M. (2006). Distribution and elimination of fumonisin analogues in weaned piglets after oral administration of Fusarium verticillioides fungal culture. Food Additives and Contaminants 23: 492-501. (Pubitemid 43675284)
22. Food and Agriculture Organization (FAO) (2001) Safety Evaluation of Certain Mycotoxins in Food. In: The 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), Geneva, Switzerland, p. 557.
23. Friend D.W., Trenholm H.L., Thompson B.K., Prelusky D.B. and Hartin K.E. (1986). Effect of (DON)-contaminated diet fed to growing-finishing pigs on their performance at market weight, nitrogen retention and DON excretion. Canadian Journal of Animal Science 66: 1075-1085.
24. Gelderblom W.C.A., Jaskiewicz K., Marasas W.F.O., Thiel P.G., Horak R.M., Vleggaar R. and Kriek N.P.J. (1988). Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Applied and Environmental Microbiology 54: 1806-1811.
25. Gelderblom W.C.A., Kriek N.P.J., Marasas W.F.O. and Thiel P.G. (1991). Toxicity and carcinogenecity of the Fusarium moniliforme metabolite, fumonisin B1 in rats. Carcinogenesis 12: 1247-1251.
26. Glenn A.E. (2007). Mycotoxigenic Fusarium species in animal feed. Animal Feed Science and Technology 137: 213-240.
27. Gong Y.Y., Torres-Sanchez L., Lopez-Carrillo L., Peng J.H., Sutcliffe A.E., White K.L., Humpf H., Turner P.C. and Wild C.P. (2008). Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population. Cancer Epidemiology, Biomarkers and Prevention 17: 688-694.
28. Goyarts T. and Danicke S. (2006). Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicology Letters 163: 171-182.
29. Greenhalgh R., Levandier D., Adams W., Miller J.D., Blackwell B.A., McAlees A.J. and Taylor A. (1986). Production and characterization of deoxynivalenol and other secondary metabolites of Fusarium culmorum (CMI 14764, HLX 1503). Journal of Agricultural and Food Chemistry 34: 98-102.
30. Groopman J.D., Hasler J.A., Trudel L.J., Pikul A., Donahue P.R. and Wogan G.N. (1992 a). Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Research 52: 267-274.
31. Groopman J.D., Jiaqi Z., Donahue P.R., Pikul A., Lisheng Z., Jun-shi C. and Wogan G.N. (1992 b). Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, Peopleĝ€™s Republic of China. Cancer Reserarch 52: 45-52.
32. Groopman J.D., Wild C.P., Hasler J., Junshi C., Wogan G.N. and Kensler T.W. (1993). Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environmental Health Perspectives 99: 107-113.
33. Hopton R.P., Turner E., Burley V.J., Turner P.C. and Fisher J. (2010). Urine metabolite analysis as a function of deoxynivalenol exposure: an NMR-based metabolomics investigation. Food Additives and Contaminants Part A 27: 255-261.
34. Hulshof K.F.A.M. and Löwik M.R.H. Nutritional surveillance in industrialised countries In: Sader M.J., Strain J.J. and Caballero B. (eds), Encyclopedia of Human Nutrition, London: Academic Press, pp. 1413-1422.
35. International Agency for Research on Cancer (IARC) (1993). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 56: 397-444.
36. Iverson F., Armstrong C., Nera E., Truelove J., Fernie S., Scott P., Stapley R., Hayward S. and Gunner S. (1995). Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratogenesis, Carcinogenesis and Mutagenesis 15: 283-306.
37. Jelinek C.F., Pohland A.E. and Wood G.E. (1989). Worldwide occurrence of mycotoxins in foods and feeds-an update. Journal Association of Official Analytical Chemists 72: 223-230.
38. Jodlbauer J., Zöllner P. and Lindner W. (2000). Determination of zeranol, taleranol, zearalenone, ±- and β-zearalenol in urine and tissue by high-performance liquid chromatography-tandem mass spectrometry. Chromatographia 51: 681-687. (Pubitemid 30434934)
39. Kim D. -H., Yoo H. -S., Lee Y. -M., Kie J. -H., Jang S. and Oh S. (2006). Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice. Journal of Toxicology and Environmental Health Part A 69: 2071-2082.
40. Kleinova M., Zollner P., Kahlbacher H., Hochsteiner W. and Lindner W. (2002). Metabolic profiles of the mycotoxin zearalenone and of the growth promoter zeranol in urine, liver and muscle of heifers. Journal of Agricultural and Food Chemistry 50: 4769-4776.
41. Krska R., Pettersson H., Josephs R.D., Lemmens M., Mac Donald S. and Welzig E. (2003). Zearalenone in maize: stability testing and matrix characterization of a certified reference material. Food Additives and Contaminants 20: 1141-1152.
42. Kuiper-Goodman T., Scott P.M. and Watanabe H. (1987). Risk assessment of the mycotoxin zearalenone. Regulatory Toxicology and Pharmacology 7: 253-306.
43. Landeros P., Reyes W., Torres A.M., Rojo F. and Chulze S. (2005). Sphinganine/Sphingosine (Sa/So) ratio and intake of fumonisin contaminated tortillas in a Mexican population. Acta Toxicologica Argentina 13: 8-11.
44. Larsen J.C., Hunt J., Perrin I. and Ruckenbauer P. (2004). Workshop on trichothecenes with a focus on DON: summary report. Toxicology Letters 153: 1-22.
45. Marasas W.F.O. (1996). Fumonisins: history, world-wide occurrence and impact. Advances in Experimental Medicine and Biology 392: 1-17.
46. Massart F., Meucci V., Saggese G. and Soldani G. (2008). High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. Journal of Pediatrics 152: 690-669.
47. Meky F.A., Turner P.C., Ashcroft A.E., Miller J.D., Qiao Y.L., Roth M.J. and Wild C.P. (2003). Development of a urinary biomarker of human exposure to deoxynivalenol. Food and Chemical Toxicology 41: 265-273.
48. Merlo D.F., Sormani M.P. and Bruzzi P. (2006). Molecular epidemiology: new rules for new tools? Mutation Research: Molecular and Fundamental Mechanisms 600: 3-11.
49. Merrill A.H., Sullards M.C., Wang E., Voss K.A. and Riley R.T. (2001). Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environmental Health Perspectives 109: 283-289.
50. Merrill A.H., Wang E., Gilchrist D.G. and Riley R.T. (1993). Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Advances in Lipid Research 26: 215-234.
51. Merrill A.H., Wang E., Vales T.R., Smith E.R., Schroeder J.J., Menaldino D.S., Alexander C., Crane H.M., Xia J., Liotta D.C., Meredith F.I. and Riley R.T. (1996). Fumonisin toxicity and sphingolipid biosynthesis. Advances in Experimental Medicine and Biology 392: 297-306.
52. Minervini F., Giannoccaro A., Cavallini A. and Visconti A. (2005). Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicology Letters 159: 272-283.
53. Mirocha C.J., Pathre S.V. and Robison T.S. (1981). Comparative metabolism of zearalenone and transmission into bovine milk. Food and Cosmetics Toxicology 19: 25-30.
54. Missmer S.A., Suarez L., Felkner M., Wang E., Merrill A.H., Rothman K.J. and Hendricks K.A. (2006). Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environmental Health Perspectives 114: 237-241.
55. Morgan M.K., Schroeder J.J., Rottinghaus G.E., Powell D.C., Bursian S.J. and Aulerich R.J. (1997). Dietary fumonisins disrupt sphingolipid metabolism in mink and increase the free sphinganine to sphingosine ratio in urine but not in hair. Veterinary and Human Toxicology 39: 334-336.
56. Nelson P.E., Plattner R.D., Shackelford D.D. and Desjardins A.E. (1992). Fumonisin B1 production by Fusarium species other than F. moniliforme in section Liseola and by some related species. Applied and Environmental Microbiology 58: 984-989.
57. Nikiema P.A., Worrilow L., Traore A.S., Wild C.P. and Turner P.C. (2008). Fumonisin exposure and the sphinganine/sphingosine ratio in urine, serum and buccal cells in adults from Burkina Faso, West Africa. World Mycotoxin Journal 1: 483-491.
58. Norred W.P., Plattner R.D., Vesonder R.F., Bacon C.W. and Voss K.A. (1992). Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by rat primary hepatocytes. Food and Chemical Toxicology 30: 233-237.
59. Paustenbach D. and Galbraith D. (2006). Biomonitoring and biomarkers: exposure assessment will never be the same. Environmental Health Perspectives 114: 1143-1149.
60. Prelusky D.B., Hamilton R.M.G., Trenholm H.L. and Miller J.D. (1986). Tissue distribution and excretion of radioactivity following administration of 14C-labeled deoxynivalenol to white Leghorn hens. Fundamental of Applied Toxicology 7: 635-645.
61. Prelusky D.B., Hartin K.E., Trenholm H.L. and Miller J.D. (1988). Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundamental of Applied Toxicology 10: 276-286.
62. Prelusky D.B., Trenholm H.L. and Savard M.E. (1994). Pharmacokinetic fate of 14C-labelled fumonisin B1 in swine. Natural Toxins 2: 73-80.
63. Prelusky D.B., Veira D.M. and Trenholm H.L. (1985). Plasma pharmacokinetics of the mycotoxin deoxynivalenol following oral and intravenous administration to sheep. Journal of Environmental Science and Health Part B 20: 603-624.
64. Qiu M.F. and Liu X.M. (2001). Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1. Food Additives and Contaminants 18: 263-269.
65. Ramos A.J., Hernández E., Plá-Delfina J.M. and Merino M. (1996). Intestinal absorption of zearalenone and in vitro study of non-nutritive sorbent materials. International Journal of Pharmaceutics 128: 129-137.
66. Ribar S., Mesari† M. and Bauman M. (2001). High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in Croatia. Journal of Chromatography Part B 754: 511-519.
67. Riley R.T., An N.H., Showker J.L., Yoo H.S., Norred W.P., Chamberlain W.J., Wang E., Merrill Jr A.H., Motelin G., Beasley V.R. and Haschek W.M. (1993). Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicology and Applied Pharmacology 118: 105-112.
68. Riley R.T., Enongene E., Voss K.A., Norred W.P., Meredith F.I., Sharma R.P., Spitsbergen J., Williams D.E., Carlson D.B. and Merrill A.H. (2001). Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environmental Health Perspectives 109: 301-308.
69. Riley R.T., Wang E. and Merrill A.H. (1994). Liquid chromatographic determination of sphinganine and sphingosine: use of the free sphinganine to sphingosine ratio as biomarker for consumption of fumonisins. Journal of AOAC International 77: 533-540.
70. Rotter B.A., Prelusky D.B. and Pestka J.J. (1996). Toxicology of deoxynivalenol (vomitoxin). Journal of Toxicology and Environmental Health Part A 48: 1-34.
71. Scientific Committee on Food (SCF) (2002). Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. SCF/CS/CNTM/MYC/27 Final Report
72. Scientific Cooperation (SCOOP) (2003). Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. SCOOP Task 3.2.10 Final Report. Available at: http://ec.europa.eu/food/fs/scoop/task3210.pdf (accessed May 20, 2010 ).
73. Scott P.M. (1989). The natural occurrence of trichothecenes. In: Beasley V.R. (ed.), Trichothecene Mycotoxicosis: Pathophysiologic Effects, Boca Raton: CRC Press FL, pp. 1-26.
74. Scott P.M. (2005). Biomarkers of human exposure to ochratoxin A. Food Additives and Contaminants 22: 99-107.
75. Sewram V., Mshicileli N., Shephard G.S. and Marasas W.F.O. (2003). Fumonisin mycotoxins in human hair. Biomarkers 8: 110-118.
76. Shephard G.S. and Snijman P.W. (1999). Elimination and excretion of a single dose of the mycotoxin fumonisin B2 in a non-human primate. Food and Chemical Toxicology 37: 111-116.
77. Shephard G.S., Thiel P.G., Stockenstrom S. and Sydenham E.W. (1996). Worldwide survey of fumonisin contamination of corn and corn-based products. Journal of AOAC International 79: 671-687.
78. Shephard G.S., Thiel P.G. and Sydenham E.W. (1992). Initial studies on the toxicokinetics of fumonisin B1. Food and Chemical Toxicology 30: 277-279.
79. Shephard G.S., Thiel P.G., Sydenham E.W., Alberts J.F. and Cawood M.E. (1994 a). Distribution and excretion of a single dose of the mycotoxin fumonisin B1 in a non-human primate. Toxicon 32: 735-741.
80. Shephard G.S., Thiel P.G., Sydenham E.W. and Snijman P.W. (1995). Toxicokinetics of the mycotoxin fumonisin B2 in rats. Food and Chemical Toxicology 33: 591-595.
81. Shephard G.S., Thiel P.G., Sydenham E.W., Vleggaar R. and Alberts J.F. (1994 b). Determination of the mycotoxin fumonisin B1 and identification of its partially hydrolysed metabolites in the faeces of non-human primates. Food and Chemical Toxicology 32: 23-29.
82. Shephard G.S., Van der Westhuizen L. and Sewram V. (2007). Biomarkers of exposure to fumonisin mycotoxins: a review. Food Additives and Contaminants 24: 1196-1201.
83. Silva L.J.G., Lino C.M. and Pena A. (2009). Sphinganine-sphingosine ratio in urine from two Portuguese populations as biomarker to fumonisins exposure. Toxicon 54: 390-398.
84. Sokolovi‡ M., Garaj-Vrhovac V. and Åimpraga B. (2008). T-2 toxin: incidence and toxicity in poultry. Arhiv za Higijenu Rada i Toksikologiju 59: 43-52.
85. Solfrizzo M., Avantaggiato G. and Visconti A. (1997). In vivo validation of the sphinganine/sphingosine ratio as a biomarker to display fumonisin ingestion. Cereal Research Communications 25: 437-441.
86. Solfrizzo M., Chulze S.N., Mallmann C., Visconti A., De Girolamo A., Rojo F. and Torres A. (2004). Comparison of urinary sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure. Food Additives and Contaminants Part A 21: 1090-1095.
87. Soriano J.M., González L. and Catalá A.I. (2005). Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Progress in Lipid Research 44: 345-356.
88. Stockmann-Juvala H. and Savolainen K. (2008). A review of the toxic effects and mechanisms of action of fumonisin B1. Human and Experimental Toxicology 27: 799-809.
89. Sudakin D.L. (2003). Trichothecenes in the environment: relevance to human health. Toxicology Letters 143: 97-107.
90. Sydenham E.W., Shephard G.S., Thiel P.G., Marasas W.F.O. and Stockenström S. (1991). Fumonisin contamination of commercial corn-based human foodstuffs. Journal of Agricultural and Food Chemistry 39: 2014-2018.
91. Tanaka T., Hasegawa A., Yamamoto S., Lee U.S., Sugiura Y. and Ueno Y. (1988). Worldwide contamination of cereals by the Fusarium mycotoxins nivalenol, deoxynivalenol and zearalenone. 1. Survey of 19 countries. Journal of Agricultural and Food Chemistry 36: 979-983.
92. Tran S.T., Tardieu D., Auvergne A., Bailly J.D., Babile R., Durand S., Benard G. and Guerre P. (2006). Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks. Chemico-Biological Interactions 160: 41-50. (Pubitemid 43227480)
93. Turner P.C., Burley V.J., Rothwell J.A., White K.L.M., Cade J.E. and Wild C.P. (2008 b). Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. Journal of Exposure Science and Environmental Epidemiology 18: 392-399.
94. Turner P.C., Burley V.J., Rothwell J.A., White K.L.M., Cade J.E. and Wild C.P. (2008 c). Deoxynivalenol: rationale for development and application of a urinary biomarker. Food Additives and Contaminants 25: 86-871.
95. Turner P.C., Nikiema P. and Wild C.P. (1999). Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks. Mutation Research 443: 81-93.
96. Turner P.C., Rothwell J.A., White K.L., Gong Y., Cade J.E. and Wild C.P. (2008 a). Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environmental Health Perspectives 116: 21-25.
97. Turner P.C., Taylor E.F., White K.L.M., Cade J.E. and Wild C.P. (2009). A comparison of 24 h urinary deoxynivalenol with recent versus average cereal consumption for UK adults. British Journal of Nutrition 102: 1276-1279.
98. Ueno Y., Tashiro F. and Kobayashi T. (1983). Species differences in zearalenone-reductase activity. Food and Chemical Toxicology 21: 167-173.
99. Van der Westhuizen L., Brown N.L., Marasas W.F.O., Swanevelder S. and Shephard G.S. (1999). Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. Food and Chemical Toxicology 37: 1153-1158.
100. Van der Westhuizen L., Shephard G.S., Rheeder J.P., Somdyala N.I.M. and Marasas W.F.O. (2008). Sphingoid base levels in humans consuming fumonisin-contaminated maize in rural areas of the former Transkei, South Africa: a cross-sectional study. Food Additives and Contaminants Part A 25: 1385-1391.
101. Van der Westhuizen L., Shephard G.S. and Van Schalkwyk D.J. (2001). The effect of a single gavage dose of fumonisin B2 on the sphinganine and sphingosine concentrations in vervet monkeys. Food and Chemical Toxicology 39: 455-459.
102. Verdonck F.A.M., Sioen I., Baert K., Van Thuyne N., Bilau M., Matthys C., De Henauw S., De Meulenaer B., Devlieghere F., Van Camp J., Vanrolleghem P.A., Van Sprang P., Verbeke W. and Willems J. (2006). Uncertainty and variability modelling of chemical exposure through food. Archives of Public Health 64: 159-173.
103. Verdonck F.A.M., Van Sprang P.A. and Vanrolleghem P.A. (2005). Uncertainty and precaution in European environmental risk assessment of chemicals. Water Science and Technology 52: 227-234.
104. Visconti A. (2001). Problems associated with Fusarium mycotoxins in cereals. Bulletin of the Institute for Comprehensive Agricultural Sciences, Kinki University 9: 39-55.
105. Visconti A., Doko M.B., Solfrizzo M., Pascale M. and Boenke A. (1996). European inter-comparison study for the determination of Fumonisins in Maize. Mikrochimica Acta 123: 55-61.
106. Visconti A., Minervini F., Lucivero G. and Gambatesa V. (1991). Cytotoxic and immunotoxic effects of Fusarium mycotoxins using a rapid colorimetric bioassay. Mycopathologia 113: 181-186.
107. Voss K.A., Smith G.W. and Haschek W.M. (2007). Fumonisins: toxicokinetics, mechanism of action and toxicity. Animal Feed Science and Technology 137: 299-325.
108. Walter M.D. (1998). Food Frequency Methods. In: Kelsey J.L., Marmot M.G., Stolley P.D. and Vessey M.P. (eds), Nutritional Epidemiology, Oxford: Oxford University Press, pp. 74-94.
109. Wan Norhasima W.M., Abdulamir A.S., Abu Bakar F., Son R. and Norhafniza A. (2009). The health and toxic adverse effects of Fusarium fungal mycotoxin, fumonisins, on human population. American Journal of Infectious Diseases 5: 280-288.
110. Wang E., Norred W.P., Bacon C.W., Riley R.T. and Merrill J.A.H. (1991). Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. Journal of Biological Chemistry 266: 14486-14490.
111. Wang E., Riley R.T., Meredith F.I. and Merrill J.A.H. (1999). Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine. Journal of Nutrition 129: 214-220.
112. Wang E., Ross P.F., Wilson T.M., Riley R.T. and Merrill J.A.H. (1992). Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. Journal of Nutrition 122: 1706-1716.
113. Wild C.P., Hudson G.J., Sabbioni G., Chapot B., Hall A.J., Wogan G.N., Whittle H., Montesano R. and Groopman J.D. (1992). Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in the Gambia, West Africa. Cancer Epidemiology, Biomarkers and Prevention 1: 229-234.
114. Wild C.P., Jiang Y.-Z., Allen S.J., Jansen L.A.M., Hall A.J. and Montesano R. (1990 a). Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis 11: 2271-2274.
115. Wild C.P., Jiang Y.-Z., Sabbioni G., Chapot B. and Montesano R. (1990 b). Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Research 50: 245-251.
116. Wood G.E. (1992). Mycotoxins in foods and feeds in the United States. Journal of Animal Science 70: 3941-3949.
117. World Health Organization (WHO) (1993). International Programme on Chemical Safety, Biomarkers and Risk Assessment: Concepts and Principles, Environmental Health Criteria 155. Geneva, Switzerland: World Health Organization.
118. World Health Organization (WHO) (1997). Guidelines for predicting dietary intake of pesticide residues. 2nd revised edn, Geneve, Switzerland: World Health Organization, Document WHO/ FSF/FOS/97.7.
119. World Health Organization (WHO) (2001). Fumonisins. Safety Evaluation of Certain Mycotoxins in Food. WHO Food Additives Series 47, FAO Food and Nutrition Paper 74. Geneva, Switzerland: WHO, pp. 103-279.
120. Yoo H., Norred W.P., Showker J. and Riley R.T. (1996). Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicology and Applied Pharmacology 138: 211-218.
121. Yoshizawa T., Mirocha C.J., Behrens J.C. and Swanson S.P. (1981). Metabolic fate of T-2 toxin in a lactating cow. Food and Cosmetics Toxicology 19: 31-39.
122. Yoshizawa T., Yamashita A. and Luo Y. (1994). Fumonisin occurrence in corn from high-risk and low-risk areas for human esophageal cancer in China. Applied and Environmental Microbiology 60: 1626-1629.
123. Zölner P., Jodlbauer J., Kleinova M., Kahlbacher H., Kuhn T., Hochsteiner W. and Lindner W. (2002). Concentration levels of zearalenone and its metabolites in urine, muscle tissue and liver samples of pigs fed with mycotoxin-contaminated oats. Journal of Agricultural and Food Chemistry 50: 2494-2501.